A modified mRNA influenza vaccine has been tested in a trial, with results suggesting it may be more effective than a standard flu vaccine. The vaccine has been found to induce immunity and show superior efficacy against symptomatic illness in adults, compared to other types of flu vaccines. The outcomes of the trial indicate that the mRNA flu vaccine may be a more effective option, although the specifics of the comparison and the trial's findings are still being reported.